210 related articles for article (PubMed ID: 22716136)
1. Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies.
Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; McGuire PK
Curr Pharm Des; 2012; 18(32):5045-54. PubMed ID: 22716136
[TBL] [Abstract][Full Text] [Related]
2. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
[TBL] [Abstract][Full Text] [Related]
3. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Weinstein A; Livny A; Weizman A
Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids, reward processing, and psychosis.
Gunasekera B; Diederen K; Bhattacharyya S
Psychopharmacology (Berl); 2022 May; 239(5):1157-1177. PubMed ID: 33644820
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the antipsychotic properties of cannabidiol in humans.
Iseger TA; Bossong MG
Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.
Batalla A; Crippa JA; Busatto GF; Guimaraes FS; Zuardi AW; Valverde O; Atakan Z; McGuire PK; Bhattacharyya S; Martín-Santos R
Curr Pharm Des; 2014; 20(13):2168-85. PubMed ID: 23829359
[TBL] [Abstract][Full Text] [Related]
7. Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
[TBL] [Abstract][Full Text] [Related]
8. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
9. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
Zuardi AW; Crippa JA; Hallak JE; Bhattacharyya S; Atakan Z; Martin-Santos R; McGuire PK; Guimarães FS
Curr Pharm Des; 2012; 18(32):5131-40. PubMed ID: 22716160
[TBL] [Abstract][Full Text] [Related]
10. Δ
Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.
Colizzi M; Ruggeri M; Bhattacharyya S
Front Psychol; 2020; 11():833. PubMed ID: 32528345
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of cannabis: Lessons learned from human experimental studies.
Colizzi M; Bhattacharyya S
Prog Brain Res; 2018; 242():179-216. PubMed ID: 30471680
[TBL] [Abstract][Full Text] [Related]
13. Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology.
Bhattacharyya S; Crippa JA; Martin-Santos R; Winton-Brown T; Fusar-Poli P
Curr Pharm Des; 2009; 15(22):2603-14. PubMed ID: 19689331
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
[TBL] [Abstract][Full Text] [Related]
15. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging in cannabis use: a systematic review of the literature.
Martín-Santos R; Fagundo AB; Crippa JA; Atakan Z; Bhattacharyya S; Allen P; Fusar-Poli P; Borgwardt S; Seal M; Busatto GF; McGuire P
Psychol Med; 2010 Mar; 40(3):383-98. PubMed ID: 19627647
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.
Kayir H; Ruffolo J; McCunn P; Khokhar JY
Curr Top Behav Neurosci; 2023; 63():437-461. PubMed ID: 36318403
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Cannabidiol on Human Brain Function: A Systematic Review.
Batalla A; Bos J; Postma A; Bossong MG
Front Pharmacol; 2020; 11():618184. PubMed ID: 33551817
[No Abstract] [Full Text] [Related]
20. A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.
Cupo L; Plitman E; Guma E; Chakravarty MM
Transl Psychiatry; 2021 Apr; 11(1):217. PubMed ID: 33850098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]